In 2023, the number of patents in the biotechnology sector in Switzerland was 278.67. The forecasted data for the next five years shows a steady annual increase. For 2024, the figure is projected at 284.74, advancing to 290.78 in 2025. By 2026, the number of patents is expected to reach 296.77, continuing to 302.72 in 2027, and finally hitting 308.62 in 2028.
Year-on-year, the average growth rate is around 2.1%. Specifically, the market sees incremental gains each year: 2.2% in 2025, 2.06% in 2026, 2% in 2027, and 1.95% in 2028. Over the last two years, the trend indicates consistent growth, and the five-year CAGR stands at approximately 2%.
- Future trends to watch:
- Advances in genetic engineering and synthetic biology driving patent filings.
- Increasing government and private sector investments in biotech research.
- Emergence of personalized medicine and biopharmaceutical innovations.
- Regulatory changes and international collaborations influencing patent activity.
